Evidence map›Paper›PMID 30733305›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2019

Biomarkers of Exposure among U.S. Adult Cigar Smokers: Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).

Cindy M Chang, Brian L Rostron, Joanne T Chang, Catherine G Corey, Heather L Kimmel, Connie S Sosnoff, Maciej L Goniewicz, Kathryn C Edwards, Dorothy K Hatsukami, Yuesong Wang and 12 more

Open access · greenAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 37 citations in OpenAlex.

  1. Cigarette Smokers Versus Cousers of Cannabis and Cigarettes: Exposure to Toxicants.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014).Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  7. Examining Demand and Substitutability of Usual Brand Little Cigars/Cigarillos and Cigarettes in Young Adults Who Dual Use.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2024
    Article
  8. Article
  9. Biomarkers of Toxic Exposure and Oxidative Stress Among U.S. Adult Users of Premium Cigar Versus Other Cigar Subtypes: 2013-2019.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Article
  10. Article
  11. The Associations ofInternational journal of environmental research and public health · 2023
    Article
  12. Geographic isolation predicts tobacco product use among youth: A latent class analysis.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2022
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Urinary Cotinine and Cotinine + Trans-3'-Hydroxycotinine (TNE-2) Cut-points for Distinguishing Tobacco Use from Nonuse in the United States: PATH Study (2013-2014).Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2021
    Observational
  18. Article
  19. Article
  20. Tobacco-Specific Nitrosamines (NNAL, NNN, NAT, and NAB) Exposures in the US Population Assessment of Tobacco and Health (PATH) Study Wave 1 (2013-2014).Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Cindy M ChangCenter for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland. Cindy.Chang@fda.hhs.gov.ORCID 0000-0002-2103-8222
Brian L RostronCenter for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland.
Joanne T ChangCenter for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland.ORCID 0000-0002-2103-8222
Catherine G CoreyCenter for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland.
Heather L KimmelNational Institute on Drug Abuse, National Institutes of Health, Bethedsa, Maryland.ORCID 0000-0001-8278-0095
Connie S SosnoffU.S. Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0001-9162-633X
Maciej L GoniewiczRoswell Park Comprehensive Cancer Center, Buffalo, New York.ORCID 0000-0001-6748-3068
Kathryn C EdwardsWestat, Rockville, Maryland.
Dorothy K HatsukamiMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
Yuesong WangU.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Arseima Y Del Valle-PineroCenter for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland.
Maocheng YangCenter for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland.
Mark J TraversRoswell Park Comprehensive Cancer Center, Buffalo, New York.
Stephen ArnsteinU.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Kristie TaylorWestat, Rockville, Maryland.
Kevin ConwayNational Institute on Drug Abuse, National Institutes of Health, Bethedsa, Maryland.
Bridget K AmbroseCenter for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland.ORCID 0000-0001-9263-3056
Nicolette BorekCenter for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland.
Andrew HylandRoswell Park Comprehensive Cancer Center, Buffalo, New York.
Lanqing WangU.S. Centers for Disease Control and Prevention, Atlanta, Georgia.
Benjamin C BlountU.S. Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0003-4788-8169
Dana M van BemmelCenter for Tobacco Products, Food and Drug Administration, Silver Spring, Maryland.
United States Food and Drug Administration · USCenters for Disease Control and Prevention · USRoswell Park Comprehensive Cancer Center · USNational Institute on Drug Abuse · USWestat (United States) · USUniversity of Minnesota · US

Funding

Intramural FDA HHS FD999999NIDA NIH HHS HHSN271201100027CNIDA NIH HHS HHSN271201600001C
6 · The paper itself

Abstract

backgroundGiven the diverse cigar market and limited data on biomarker patterns by cigar type, we compared biomarkers of nicotine and tobacco toxicants among cigar smokers and other groups.

methodsUsing Wave 1 urinary biomarker data from 5,604 adults in the Population Assessment of Tobacco and Health (PATH) Study, we compared geometric mean concentrations among cigar-only smokers (all cigars and separately for traditional, cigarillo, and filtered cigars), cigarette-only smokers, dual cigar/cigarette smokers, and never users of tobacco. We calculated geometric mean ratios comparing groups with never users adjusting for sex, age, race/ethnicity, education and creatinine.

resultsSome day cigar-only smokers had lower biomarker concentrations than every day cigar-only smokers, but higher than never users. Every day cigar-only smokers (

conclusionsFor some biomarkers, every day cigar-only smokers were comparable with every day cigarette-only smokers. Exploratory analyses suggest that biomarkers vary by cigar type with every day filtered cigar-only smokers having the highest concentrations. IMPACT: High exposure to harmful constituents among cigar smokers is a continuing health issue.

Indexed as

AdolescentAdultBiomarkersCarcinogensCotinineEnvironmental ExposureFemaleFollow-Up StudiesHumansMaleMiddle AgedNicotineNitrosaminesPrognosisSmokingTobacco ProductsBiomarkersCarcinogensCotinineNicotineNitrosamines

Identifiers

PMID30733305
PMCPMC6500461
OpenAlexW2912210692

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.